14-day Premium Trial Subscription Try For FreeTry Free
$0.691
+0.0110 (+1.62%)
At Close: Apr 24, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.655 $0.83 Wednesday, 24th Apr 2024 DBVT stock ended at $0.691. This is 1.62% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 7.40% from a day low at $0.665 to a day high of $0.714.
90 days $0.655 $0.95
52 weeks $0.650 $2.37

Historical DBV Technologies S.A. prices

Date Open High Low Close Volume
Apr 24, 2024 $0.714 $0.714 $0.665 $0.691 2 575
Apr 23, 2024 $0.690 $0.715 $0.660 $0.680 116 974
Apr 22, 2024 $0.656 $0.722 $0.656 $0.661 43 078
Apr 19, 2024 $0.702 $0.710 $0.660 $0.682 39 297
Apr 18, 2024 $0.724 $0.724 $0.660 $0.661 19 219
Apr 17, 2024 $0.701 $0.726 $0.675 $0.680 32 220
Apr 16, 2024 $0.690 $0.715 $0.690 $0.701 22 165
Apr 15, 2024 $0.700 $0.700 $0.690 $0.695 26 046
Apr 12, 2024 $0.685 $0.720 $0.672 $0.694 24 326
Apr 11, 2024 $0.720 $0.778 $0.700 $0.700 22 903
Apr 10, 2024 $0.733 $0.733 $0.710 $0.720 3 209
Apr 09, 2024 $0.80 $0.80 $0.700 $0.734 64 634
Apr 08, 2024 $0.760 $0.83 $0.734 $0.770 74 630
Apr 05, 2024 $0.666 $0.789 $0.666 $0.770 79 675
Apr 04, 2024 $0.750 $0.80 $0.655 $0.700 175 158
Apr 03, 2024 $0.773 $0.799 $0.745 $0.750 45 798
Apr 02, 2024 $0.776 $0.792 $0.760 $0.765 43 390
Apr 01, 2024 $0.757 $0.82 $0.731 $0.780 45 447
Mar 28, 2024 $0.732 $0.760 $0.720 $0.749 14 547
Mar 27, 2024 $0.81 $0.82 $0.730 $0.767 124 751
Mar 26, 2024 $0.82 $0.82 $0.759 $0.776 12 900
Mar 25, 2024 $0.776 $0.790 $0.746 $0.785 15 634
Mar 22, 2024 $0.762 $0.796 $0.760 $0.796 42 454
Mar 21, 2024 $0.784 $0.80 $0.770 $0.80 27 274
Mar 20, 2024 $0.780 $0.81 $0.755 $0.81 13 186
Click to get the best stock tips daily for free!

About DBV Technologies S.A.

DBV Technologies S.A. DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical t... DBVT Profile

Golden Star

Ticker Date Change Price
LPLA Apr 19 1.64% $262.59
MLI Apr 19 9.87% $52.28
LNG Apr 17 1.33% $156.81
FCN Apr 16 2.58% $207.62
ELV Apr 16 5.12% $506.97
DXC Apr 08 1.39% $20.87
ITCI Apr 05 8.14% $68.44
AKR Apr 05 6.84% $16.53
NSIT Apr 04 0.350% $185.62
VSTS Apr 04 0.638% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT